RA
Radiopharm Theranostics Limited (RADX)
NASDAQ·Healthcare·Biotechnology
$2.05
-0.49%
Mkt Cap $6.36M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+192.7%
Consensus $6.00 vs current $2.05
NASDAQ·Healthcare·Biotechnology
$2.05
-0.49%
Mkt Cap $6.36M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+192.7%
Consensus $6.00 vs current $2.05